Three grants totaling more than $25 million over four years will help three research groups to develop authoritative information on the millions of genomic variants relevant to human disease and the hundreds that are expected to be useful for clinical practice. The awards are from the National Institutes of Health.

Related posts:

  1. Medicare Card, NHGRI to develop revolutionary technologies for exploring genome function The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has awarded 10 grants, totaling $10.5 million, to develop revolutionary technologies that will help researchers identify millions of genomic elements that play a role in determining what genes are expressed and at what levels in different cells. These multi-year grants are […]...
  2. Make a mightier mouse resource for understanding disease Over the next five years, National Institutes of Health (NIH)-funded researchers will extensively test and generate data about mice with disrupted genes to gain clues about human diseases. NIH today awarded a set of cooperative agreements totaling more than $110 million to begin the second phase of the Knockout Mouse Project (KOMP)....
  3. eMERGE network moves closer to tailored treatments based on patients’ genomic information Researchers in the Electronic Medical Records and Genomics (eMERGE) network will receive $25 million over the next four years to demonstrate that patients’ genomic information linked to disease characteristics and symptoms in their electronic medical records can be used to improve their care. The grants are from the National Human Genome Research Institute (NHGRI), part […]...
  4. Reach of national clinical and translational research consortium The National Institutes of Health announced that it will provide $200 million over five years to five health research centers to speed scientific discoveries into treatments for patients. The grants were awarded as part of the Clinical and Translational Science Awards (CTSA) program, which is led by the NIH’s National Center for Research Resources (NCRR)....
  5. Medicare Card, NIH launches trial for rare degenerative muscle disease treatment Medicare Card, NIH launches trial for rare degenerative muscle disease treatment...
  6. Medicare Card, Medical Screening Tests , An Important Part of Preventative Care Medicare Card, Medical Screening Tests , An Important Part of Preventative Care...
  7. Funded research provides new clues on how ApoE4 affects Alzheimer’s risk Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer’s disease, but the gene’s role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the […]...
  8. Medicare Card, NIH-funded trial launched to assess experimental TB drug Medicare Card, NIH-funded trial launched to assess experimental TB drug...
  9. Undergraduate design challenge focuses on technology solutions in health care A competition for undergraduate students to foster the design and development of innovative diagnostic and therapeutic devices, and technologies to aid underserved populations and the disabled is being sponsored by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health....
  10. Medicare Card, Find available grants, loans, financial aid, and other benefits from the U.S. government Medicare Card, Find available grants, loans, financial aid, and other benefits from the U.S. government...
  11. MedicarCard.com, NIH, Human Microbiome Project, Researchers Publish First Genomic, Collection of Human Microbes The Human Microbiome Project (HMP) today published an analysis of 178 genomes from microbes that live in or on the human body. The researchers discovered novel genes and proteins that serve functions in human health and disease, adding a new level of understanding to what is known about the complexity and diversity of these organisms....
  12. Medicare Medical Care, Rapid Development of Drug-Resistant, 2009 H1N1 Influenza Reported in Two Cases Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Doctors who treat prolonged influenza infection should be aware that even a short course of antiviral treatment may lead to drug-resistant virus, say the authors, and clinicians should consider this possibility as they develop initial treatment strategies for their patients who have impaired immune function....
  13. Sequencing program focus on inherited diseases, medical applications A new funding plan by the National Human Genome Research Institute (NHGRI) sharpens the focus of its flagship Genome Sequencing Program on medical applications. In addition to continuing on-going studies, the four-year, $416 million plan launches new efforts to find causes of rare inherited diseases and accelerate the use of genome sequence information in the […]...
  14. NIH Genomic Mapping Study Finds Largest Set of Genes Related to Major Risk Factor for Heart Disease Scanning the genomes of more than 100,000 people from all over the world, scientists report the largest set of genes discovered underlying high cholesterol and high triglycerides — the major risk factors for coronary heart disease, the nation’s number one killer. Taken together, the gene variants explain between a quarter and a third of the […]...
  15. NHGRI funds development of revolutionary DNA sequencing technologies Researchers today received more than $14 million in grants to develop DNA sequencing technologies that will rapidly sequence a person’s genome for $1000 or less. The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, awarded the grants to enable the everyday use of DNA sequencing technologies by biomedical researchers and […]...